These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16683966)

  • 1. Transcranial magnetic stimulation for depression.
    Mitchell PB; Loo CK
    Aust N Z J Psychiatry; 2006 May; 40(5):406-13. PubMed ID: 16683966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials.
    Berlim MT; Van den Eynde F; Daskalakis ZJ
    J Clin Psychiatry; 2013 Feb; 74(2):e122-9. PubMed ID: 23473357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Repetitive transcranial magnetic stimulation in major depression: response factor].
    Dumas R; Padovani R; Richieri R; Lançon C
    Encephale; 2012 Sep; 38(4):360-8. PubMed ID: 22980479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression.
    Fitzgerald PB; Benitez J; de Castella A; Daskalakis ZJ; Brown TL; Kulkarni J
    Am J Psychiatry; 2006 Jan; 163(1):88-94. PubMed ID: 16390894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
    George MS; Lisanby SH; Avery D; McDonald WM; Durkalski V; Pavlicova M; Anderson B; Nahas Z; Bulow P; Zarkowski P; Holtzheimer PE; Schwartz T; Sackeim HA
    Arch Gen Psychiatry; 2010 May; 67(5):507-16. PubMed ID: 20439832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: replication study in drug-free patients.
    Brakemeier EL; Wilbertz G; Rodax S; Danker-Hopfe H; Zinka B; Zwanzger P; Grossheinrich N; Várkuti B; Rupprecht R; Bajbouj M; Padberg F
    J Affect Disord; 2008 May; 108(1-2):59-70. PubMed ID: 17963846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a meta-analysis of stimulus parameter effects.
    Xie J; Chen J; Wei Q
    Neurol Res; 2013 Dec; 35(10):1084-91. PubMed ID: 23889926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of repetitive transcranial magnetic stimulation in the treatment of depression.
    Fitzgerald PB; Daskalakis ZJ
    Expert Rev Med Devices; 2011 Jan; 8(1):85-95. PubMed ID: 21158543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance repetitive transcranial magnetic stimulation (rTMS) for relapse prevention in with depression: A review.
    Rachid F
    Psychiatry Res; 2018 Apr; 262():363-372. PubMed ID: 28951141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic application of repetitive transcranial magnetic stimulation for major depression].
    Nakamura M
    Seishin Shinkeigaku Zasshi; 2012; 114(11):1231-49. PubMed ID: 23367835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression.
    Blumberger DM; Mulsant BH; Fitzgerald PB; Rajji TK; Ravindran AV; Young LT; Levinson AJ; Daskalakis ZJ
    World J Biol Psychiatry; 2012 Sep; 13(6):423-35. PubMed ID: 21736507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of the anti-depressant effects of low- and high-frequency transcranial magnetic stimulation in treatment-resistant depression.
    Fitzgerald PB; Hoy K; Daskalakis ZJ; Kulkarni J
    Depress Anxiety; 2009; 26(3):229-34. PubMed ID: 19105212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repetitive transcranial magnetic stimulation (rTMS) for treating major depression and schizophrenia: a systematic review of recent meta-analyses.
    Hovington CL; McGirr A; Lepage M; Berlim MT
    Ann Med; 2013 Jun; 45(4):308-21. PubMed ID: 23687987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in treatment-resistant major depression.
    Fitzgerald PB; Hoy K; Gunewardene R; Slack C; Ibrahim S; Bailey M; Daskalakis ZJ
    Psychol Med; 2011 Jun; 41(6):1187-96. PubMed ID: 20925972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis on the efficacy and acceptability of bilateral repetitive transcranial magnetic stimulation (rTMS) for treating major depression.
    Berlim MT; Van den Eynde F; Daskalakis ZJ
    Psychol Med; 2013 Nov; 43(11):2245-54. PubMed ID: 23200131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial magnetic stimulation in adolescent depression.
    Loo C; McFarquhar T; Walter G
    Australas Psychiatry; 2006 Mar; 14(1):81-5. PubMed ID: 16630205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
    Nguyen KH; Gordon LG
    Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of vascular depression using repetitive transcranial magnetic stimulation.
    Jorge RE; Moser DJ; Acion L; Robinson RG
    Arch Gen Psychiatry; 2008 Mar; 65(3):268-76. PubMed ID: 18316673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.
    Paillère Martinot ML; Galinowski A; Ringuenet D; Gallarda T; Lefaucheur JP; Bellivier F; Picq C; Bruguière P; Mangin JF; Rivière D; Willer JC; Falissard B; Leboyer M; Olié JP; Artiges E; Martinot JL
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):45-59. PubMed ID: 19267956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.